 CAMBRIDGE, United Kingdom and CAMBRIDGE, Mass., Aug. 02, 2021 GLOBE NEWSWIRE -- F-star Therapeutics, Inc. NASDAQ: FSTX, a clinical-stage biopharmaceutical company dedicated to developing next generation immunotherapies to transform the lives of patients with cancer, announced today that it will release earnings for the quarter ending June 30, 2021 before market open on August 12, 2021. The Company will host an investor conference call and webcast that same day at 9:00 a.m. EST to discuss financial results and provide a corporate update. 